Sarah Payne, MBBS PhD FRCP

Sarah Payne, MBBS PhD FRCP, is a Senior Global Development Medical Director at AstraZeneca with extensive experience in medical oncology and pharmaceutical industry roles.1 Here are some key details about her career:

Current Role

Sarah Payne joined AstraZeneca in September 2023 as Senior Global Development Medical Director in Late Development Oncology Bispecifics. In this role, she is responsible for leading key lung cancer studies as part of the phase III program.1

Previous Experience

At AstraZeneca::

• Senior Global Medical Manager for Prostate Cancer (August 2022 - September 2023)
• Senior Global Medical Affairs Leader (January 2020 - August 2022)
• Global Medical Affairs Leader (March 2018 - January 2020)

Other Roles::

• Honorary Medical Oncology Consultant at Guy's and St Thomas' NHS Foundation Trust (November 2015 - April 2023)
• Medical Affairs Manager at Pfizer (November 2015 - March 2018)

Background

Sarah Payne has over 20 years of experience in medical oncology as a clinician. She specialized in upper GI cancers during her time as an Honorary Medical Oncology Consultant at Guy's and St Thomas' NHS Trust.1

Education

She holds an MBBS (Bachelor of Medicine, Bachelor of Surgery), a PhD, and is a Fellow of the Royal College of Physicians (FRCP).1

Sarah Payne has built her industry career over the past seven years, gaining both country-level and global industry experience. Her expertise spans pre-launch, launch, and post-launch activities in oncology, with a focus on delivering better sustainable healthcare solutions for patients.1